TKNO - NASDAQ
Alpha Teknova, Inc.
$5.13
-0.97%Alpha Teknova, Inc. provides critical reagents for life sciences market in the United States and internationally. Its reagents enable the discovery, development, and production of biopharmaceutical products, such as drug therapies, novel vaccines, and molecular diagnostics. The company offers pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. It serves life sciences market, including pharmaceutical and biotechnology companies, contract development and manufacturing organizations, in vitro diagnostic franchises, and academic and government research institutions. The company was founded in 1996 and is headquartered in Hollister, California.
At a Glance
Live SnapshotAlpha Teknova, Inc. Management Team
Mr. Matthew C. Lowell
Chief Financial Officer
Compensation
$591,500
Mr. Damon A. Terrill J.D.
General Counsel, Chief Compliance Officer & Secretary
Compensation
$570,898
Mr. Stephen Gunstream
President, Chief Executive Officer & Director
Compensation
$932,301
Ms. Jennifer Henry
Senior Vice President of Marketing
Alpha Teknova, Inc. Insider Positioning
During the last 12 months, insiders have purchased $1.02M and sold $41K worth of TKNO shares, resulting in $981K of net buying activity.
3 Months
66.0K
143.42K
0
0.00
+143K
+$143K
3-6 Months
0
0.00
0
0.00
+0
+$0
6-9 Months
0
0.00
0
0.00
+0
+$0
9-12 Months
162.9K
878.03K
8.0K
40.51K
+838K
+$838K
Top Buyers
Vos Alexander
Director
$293K
Robertson Brett
Director
$293K
Demski Martha J
Director
$293K
Lowell Matthew
Officer: Chief Financial Officer
$88K
Gunstream Stephen
Director, Officer: President And Ceo
$56K
Top Sellers
Demski Martha J
Director
$41K
Insider Activity Analysis
Net Insider Sentiment
Strong bullish signal with $981K net buying. Insiders are aggressively accumulating shares, suggesting significant confidence in future prospects.
Buy/Sell Ratio
Exceptional buy/sell ratio. Buying dramatically outweighs selling—one of the strongest possible insider signals.
Recent Trend (3 Months)
Very strong recent buying momentum. Recent insider purchases significantly outpace sales, suggesting near-term optimism.
Insider Participation
5 insider buyers vs. 1 sellers. Broad-based buying across management team suggests widespread confidence.
Insider Activity Insight
Strong confluence of bullish signals: High buy/sell ratio, multiple insiders participating, and recent buying momentum all point to significant insider confidence. This level of coordinated buying often precedes positive developments.
SEC Filings
TKNO - Filing history and reports
| Filing Type | Filing Date | Period Ending | Fiscal Year | Actions |
|---|---|---|---|---|
DEF 14A DEF 14A 2026 N/A | April 21, 2026 | April 21, 2026 | 2026 | |
DEF 14A DEF 14A 2025 N/A | April 28, 2025 | June 17, 2025 | 2025 | |
DEF 14A DEF 14A 2024 N/A | April 29, 2024 | June 24, 2024 | 2024 | |
DEF 14A DEF 14A 2023 N/A | April 28, 2023 | June 13, 2023 | 2023 | |
DEF 14A DEF 14A 2022 N/A | April 28, 2022 | June 02, 2022 | 2022 |
Research Paths
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.